InvestorsHub Logo

StealthGold

05/04/22 11:02 AM

#208124 RE: JPG77 #208123

The NASH PH2 trial is made up of two arms - 350mg open label and 700mg blinded. Publishing only the 350mg arm data and saying the trial met its end points is simply untrue. These are the kinds of claims the FDA frowned upon and the SEC and DOJ are looking into. Hence you will not find this anywhere on the CYDY website

justdafactss

05/04/22 11:03 AM

#208125 RE: JPG77 #208123

CYDY said they filed an EUA but that was a lie too.

What clinical data from a govt entity like clinical trials.gov verifies HIV and NASH endpoints were met?

Should be easy to verify if they exist. I could not find that data that verifies HIV and NASH endpoints were met.

kgromax

05/04/22 11:56 AM

#208130 RE: JPG77 #208123

The only thing funny with Cytodyn is how it always goes down after longs challenge each and every common sense assertion. Short sellers have been correct in each of these discussions. Not very funny it seems.